Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Weed Out the Losers: Cramer's 'Mad Money' Recap (Thursday 8/20/20)
By Scott Rutt
Aug 20, 2020 7:59 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present New Data Analyses Of Once-Daily ONGENTYS® (opicapone) In Patients With Parkinson's Disease At The American Neurological Association 2020 Virtual Meeting
By PR Newswire
Sep 28, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences Announces Once-Daily ONGENTYS® (opicapone) Now Available In The U.S. As An Add-On Treatment For Patients With Parkinson's Disease Experiencing "Off" Episodes
By PR Newswire
Sep 14, 2020 8:44 AM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The Morgan Stanley 18th Annual Global Healthcare Conference
By PR Newswire
Sep 8, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present New Data From Its Movement Disorder Programs For Tardive Dyskinesia And Parkinson's Disease At Upcoming Scientific Meetings
By PR Newswire
Sep 3, 2020 4:06 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The Citi 15th Annual BioPharma Virtual Conference
By PR Newswire
Sep 2, 2020 4:01 PM EDT
JIM CRAMER
Weed Out the Losers: Cramer's 'Mad Money' Recap (Thursday 8/20/20)
By Scott Rutt
Aug 20, 2020 7:59 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Participate At The William Blair Biotech Focus Conference 2020
By PR Newswire
Jul 30, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences Announces Conference Call And Webcast Of Second Quarter 2020 Financial Results
By PR Newswire
Jul 13, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences And Takeda Announce Collaboration To Develop And Commercialize Potential Therapies For Psychiatric Disorders
By Business Wire
Jun 16, 2020 7:00 AM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The Bank Of America Securities 2020 Napa Biopharma Conference
By PR Newswire
Jun 15, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The Goldman Sachs 41st Annual Global Healthcare Conference Webcast
By PR Newswire
Jun 4, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The Jefferies Virtual Healthcare Conference
By PR Newswire
May 26, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At The RBC Capital Markets 2020 Global Healthcare Conference
By PR Newswire
May 14, 2020 7:29 PM EDT
PRESS RELEASES
Neurocrine Biosciences Exercises Option To License Idorsia's Novel Treatment For Rare Pediatric Epilepsy
By PR Newswire
May 11, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At Bank Of America Merrill Lynch Health Care Conference 2020
By PR Newswire
May 5, 2020 4:01 PM EDT
INVESTING
Neurocrine Biosciences Parkinson's Drug Cleared by FDA
By Dan Weil
Apr 27, 2020 11:07 AM EDT
PRESS RELEASES
Neurocrine Biosciences Announces FDA Approval Of Once-Daily ONGENTYS® (opicapone) As An Add-On Treatment For Patients With Parkinson's Disease Experiencing "Off" Episodes
By PR Newswire
Apr 27, 2020 7:30 AM EDT
PRESS RELEASES
Neurocrine Biosciences Announces Conference Call And Webcast Of First Quarter 2020 Financial Results
By PR Newswire
Apr 15, 2020 4:01 PM EDT
PRESS RELEASES
Neurocrine Biosciences Provides COVID-19 Business Update
By PR Newswire
Apr 3, 2020 8:30 AM EDT
PRESS RELEASES
Neurocrine Biosciences To Present At Cowen 40th Annual Health Care Conference
By PR Newswire
Feb 25, 2020 4:01 PM EST
PRESS RELEASES
Neurocrine Biosciences Announces Appointment Of Shalini Sharp To Board Of Directors
By PR Newswire
Feb 3, 2020 5:00 PM EST
PRESS RELEASES
Neurocrine Biosciences Announces Conference Call And Webcast Of Fourth Quarter And Year-End 2019 Financial Results
By PR Newswire
Jan 20, 2020 4:30 PM EST
PRESS RELEASES
Neurocrine Biosciences Provides Preliminary Fourth Quarter And Full-Year 2019 Net Product Sales Results And 2020 Program Milestones
By PR Newswire
Jan 12, 2020 6:30 PM EST
PRESS RELEASES
Neurocrine Biosciences And Idorsia Amend Option Agreement To License Novel Treatment For Rare Pediatric Epilepsy
By PR Newswire
Jan 9, 2020 8:00 PM EST
